Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Capital One Financial I Pref | COF-I | Sep 30, 2024 | 21.45 | -2.01 |
Capital One Financial J Pref | COF-J | Sep 30, 2024 | 20.23 | -2.32 |
Capital One Financial K Pref | COF-K | Sep 30, 2024 | 20.51 | -2.09 |
Capital One Financial L Pref | COF-L | Sep 30, 2024 | 19.76 | -1.69 |
Capital One Financial N Pref | COF-N | Sep 30, 2024 | 19.43 | -1.57 |
Capital Southwest | CSWC | Sep 30, 2024 | 25.29 | -0.82 |
Capitol Federal Financial | CFFN | Sep 30, 2024 | 5.84 | +1.21 |
Capri Holdings | CPRI | Sep 30, 2024 | 42.44 | +7.52 |
Capricor Therapeutics | CAPR | Sep 30, 2024 | 15.21 | +52.86 |
Captivision | CAPT | Sep 30, 2024 | 1.97 | -4.10 |
Cara Therapeutics | CARA | Sep 30, 2024 | 0.31 | +0.98 |
Caravelle International Group | CACO | Sep 30, 2024 | 0.44 | 0.00 |
Carbon Revolution | CREV | Sep 30, 2024 | 4.58 | -1.93 |
Cardiff Oncology | CRDF | Sep 30, 2024 | 2.67 | -3.61 |
Cardinal Health | CAH | Sep 30, 2024 | 110.52 | +0.66 |
Cardio Diagnostics | CDIO | Sep 30, 2024 | 0.22 | +1.73 |
Cardiol Therapeutics | CRDL | Sep 30, 2024 | 1.98 | -4.35 |
Cardlytics | CDLX | Sep 30, 2024 | 3.20 | -1.84 |
CareCloud | CCLD | Sep 30, 2024 | 2.64 | +2.33 |
CareCloud A Pref | CCLDP | Sep 30, 2024 | 11.96 | -3.16 |
CareCloud B Pref | CCLDO | Sep 30, 2024 | 13.30 | 0.00 |
CareDx | CDNA | Sep 30, 2024 | 31.23 | +5.13 |
CareMax A | CMAX | Sep 30, 2024 | 1.70 | -2.30 |
CareTrust REIT | CTRE | Sep 30, 2024 | 30.86 | +0.33 |
CARGO Therapeutics | CRGX | Sep 30, 2024 | 18.45 | +5.91 |
CarGurus A | CARG | Sep 30, 2024 | 30.03 | +1.15 |
Caribou Biosciences | CRBU | Sep 30, 2024 | 1.96 | -1.01 |
Carisma Therapeutics | CARM | Sep 30, 2024 | 0.98 | -2.81 |
Carlisle Companies | CSL | Sep 30, 2024 | 449.75 | +1.16 |
Carlyle Credit Income Fund | CCIA | Sep 30, 2024 | 25.90 | +0.45 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.